The combination of trabectedin (Yondelis; Pharma Mar, Johnson & Johnson) and olaparib (Lynparza; AstraZeneca, Merck) may be a meaningful treatment for certain patients with advanced soft tissue ...

When 23-year-old Brooke Bailey began experiencing intense hip pain, doctors blamed it on her height and sitting for long ...

InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company, announced today that its next-generation TRK inhibitor, zurletrectinib (ICP-723), has received approval from the China ...

A new Curtin University study has found that people diagnosed with sarcoma—a cancer disproportionately affecting teenagers and young adults—are being left without the resources they urgently need.

Laura Isom thought her muscle pain “wasn’t much to worry about” until she was given a diagnosis that “devastated her” Sarcoma UK Laura Isom, a 58-year-old mom from England, thought her arm pain was ...

Today’s the American Cancer Society’s 49th annual Great American Smokeout, as Iowa smokers are encouraged to give up the routine for at least this one day, or to make a plan to quit. Studies find the ...

If everyone eligible had a lung cancer screening, 62,000 lives would be saved over five years, a new study shows. By Simar Bajaj Tens of thousands of lives could be saved if more people got screened ...

Patients with colon cancer using GLP-1 receptor agonists (the class of drugs behind treatments like Ozempic, Wegovy, and Mounjaro) had substantially lower five-year death rates than those not using ...

BEIRUT — Crisis-stricken Lebanon is facing yet another challenge: a surge in cancer cases and cancer-related deaths, which researchers say is rising faster than anywhere else in the world. A study ...

In 2023, more than 9,000 people in Louisiana died from cancer, at a rate of 165.1 cancer-related deaths per 100,000 people. That's higher than the U.S. cancer death rate at 145.4 cancer-related deaths ...

Significant progress is being made in the fight against lung cancer, according to a new study from the American Lung Association. But more work needs to be done. A state-by-state analysis says ...

Initiating statins within 3 years of diagnosis of early-stage breast cancer was associated with a modest but clinically meaningful 10% lower risk of dying from breast cancer and an 8% lower risk of ...